Skip to main content
. 2018 Nov 7;8:16499. doi: 10.1038/s41598-018-34738-4

Table 1.

Total number analyzed, number of mutated individuals and mean mutation rate (% of individuals detected with mutations) of channel catfish (Ictalurus punctatus) dead embryos and embryos surviving to the fingerling stage (four months) that were microinjected at the one-cell stage with three dosages of gRNA/Cas9 protein targeting toll/interleukin 1 receptor domain-containing adapter molecule (TICAM 1) gene and rhamnose binding lectin (RBL) gene.

Treatment Dead embryos Surviving fingerlings
Total analyzed Mutated Mean mutation % ± SEM Total analyzed Mutated Mean mutation % ± SEM
TICAM 1*
Low 22 15 68.2 ± 5.51 50 30 60.0 ± 1.12
Medium 19 16 84.2 ± 11.81 13 9 69.2 ± 28.57
High 25 22 88.0 ± 7.39 16 12 75.0 ± 13.33
RBL**
Low 26 23 88.5 ± 7.22 33 26 78.8 ± 4.84
Medium 26 24 92.3 ± 5.82 12 10 83.3 ± 2.86
High 28 26 92.9 ± 4.17 14 13 92.9 ± 4.17
TICAM 1 and RBL combined***
Low 48 38 79.2 ± 5.35 83 56 67.5 ± 4.96
Medium 45 40 88.9 ± 6.17 25 19 76.0 ± 12.18
High 53 48 90.6 ± 4.08 30 25 83.3 ± 7.76

The three gRNA/Cas9 protein dosages were: low dosage: 2.5 ng gRNA/7.5 ng Cas9, medium dosage: 5 ng gRNA/15 ng Cas9 and high dosage: 7.5 ng gRNA/22.5 ng Cas9.

*Positive correlation between gRNA/Cas9 dosage and mutation rate (p = 0.084).

**Positive correlation between gRNA/Cas9 dosage and mutation rate (p = 0.025).

***Positive correlation between gRNA/Cas9 dosage and mutation rate (p = 0.013).